Overview

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to examine the safety and effectiveness of intravenous MN-221 compared to placebo when administered as an adjunct to standard therapy in subjects experiencing an acute exacerbation of asthma.
Phase:
Phase 2
Details
Lead Sponsor:
MediciNova